Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Clinical trial NCT03905135 · COMPLETED

Trial details

NCT number: NCT03905135
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Peripheral T-cell Lymphoma NOS Mycosis Fungoides Sezary Syndrome Anaplastic Large Cell Lymphoma

Start date: 2019-06-07
Primary completion: 2021-03-25
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.